A Bridge app can be used to run one or more studies, which may have participants who have enrolled in more than one of these studies. Each study is sponsored by an organization, which grants permission to the members of that organization to access the study (according to their assigned roles).

Initially, only one organization will be able to sponsor a study, and a user will hold the same roles vis-a-vis every study they can access as an organization member. This will be enhanced after the initial v2 APIs are released, as part of a larger project to unify Sage Bionetwork’s two platforms—Bridge and Synapse—into a coordinated product line.

Study Lifecycle

Studies follow a lifecycle that supports the proper performance of study research. New studies are created in the design phase and are manually advanced by study owners as appropriate.

Phase Description
legacy This study was created prior to the addition of study phases, and does not participate in any of the lifecyle constraints.
design The study can be edited, including the associated schedule, and the schedule can be changed (the new schedule can be published or unpublished, and that may or may not be modifiable despite the design phase of the study). The study is not visible in public registries, and when an account is enrolled in a study in design, the test_user data group will be added to the account if it does not yet exist. The study can be logically or physically deleted by a developer, study designer, or admin. When ready, this study can be transitioned via the recruit endpoint.
recruitment To move to recruitment, the associated app should be available in the app store and the IRB approval for the study must be recorded as part of the study (there may be other criteria that must be met at this time).

The study metadata can be edited during recruitment, but the associated schedule cannot be changed, nor can that schedule itself be changed (an unpublished schedule associated to the study will be published in this transition). The study becomes visible in public registries, and accounts are enrolled normally (no test tag is added). The study cannot be logically or physically deleted. When recruitment targets have been met, this study can be transitioned via the closeEnrollment endpoint.
in_flight The study metadata can be edited, but the schedule remains immutable. The study should no longer be visible in public registries, and attempts to enroll an account in the study will be rejected (HTTP response code: 423). The study cannot be logically or physically deleted. The app should still be available in app stores in case a current participant needs to reinstall the app to continue the study. When appropriate, this study can be transitioned via the analyze endpoint. Note: the system may be able to do some checks at this time to determine all participants are finished with the study.
analysis The study can no longer be edited in any way. The study should no longer be visible in public registries, and attempts to enroll an account in the study will be rejected (HTTP response code: 423). Any uploads that are attempted once the study transitions to this state will be rejected and/or not uploaded to Synapse. The study cannot be logically or physically deleted. The app can be removed from app stores if it is not used to conduct any other studies. When this analysis is done, the study can be transitioned via the closeout endpoint.
completed The study can no longer be edited in any way. PHI information for all participants in the study will be deleted from the system (such as email, phone number, or name). The study should no longer be visible in public registries, and attempts to enroll an account in the study will be rejected (HTTP response code: 423). The study will still be available in Bridge so that final IRB reporting can occur. Once this has been done, the study can be logically deleted.
withdrawn A study can be transitioned from any other phase than completed to the withdrawn state, using the withdraw endpoint. PHI information for all participants in the study will be deleted from the system (such as email, phone number, or name). At this point the study cannot be changed at all, but the study can be logically deleted. There may be additional requirements in the future.

Information about a study for display and oversight

In addition, the Study contains important information for participants that the client will want to access to render the appropriate APIs:

Field Required Description
identifier Y A string identifier that is unique for this study in the context of the app where it is hosted (lower- or upper-case letters, numbers, dashes, and/or underscores only).
name Y The name of the study as you would like it to appear to participants.
details N This is a long form textual description of the study for prospective participants. It can embed rich text formatting (such as markdown) if the client will support rendering the notation.
studyLogoUrl N If supplied, it should be an URL to download and display a vector-graphic (SVG) logo or graphic identifying this study.
colorScheme N A set of colors that can be used to customize an app when the user is in the context of performing this study.
contacts Y An array of Contact objects that describe contact information that you intend to display to participants and other end users of the study (the array can be empty; see below).

As well, the Study contains information for study designers and for oversight:

Field Required Description
scheduleGuid (Y) The GUID of the schedule that will be used to generate a timeline for participants in this study. The GUID can be used to retrieve the appropriate Timeline through the APIs. This field is required to move into the recruitment phase. NOTE: Bridge will implement a Protocol design for v2 that includes study arms with different schedules assignable to each arm of the study. Currently Bridge implicitly assumes a study with one arm, e.g. no control vs. intervention groups.
clientData N This is an arbitrary JSON object graph that the client can use to store extra information about a study that is not specified in the Bridge schema.
institutionId N If the investigator or sponsoring institution have assigned this study an identifier of some kind, it should be recorded in this field.
disease N What disease state is this study researching? Can be general (neurodegenerative disorders) or specific (progressive supranuclear palsy). This should be a comma-delimited list when appropriate. However, the value is not constrained.
studyDesignType N What type of research design is being used in this study (intervential, observational, cohort study, cross-over, etc.). This should be a comma-delimited list when appropriate. However, the value is not constrained.
phase Y The phase of this study (see above).
irbName N The name of the IRB that approved the study or decided it was exempt from human subjects research guidelines. Optional, but can be used to identify one of several IRBs if more than one is included in the study’s contact information.
irbProtocolName N The name of the protocol as it was submitted to the IRB for approval.
irbProtocolId N The identification number issued by the IRB for the study, if any.
irbDecisionOn (Y) Before the study can launch, it must be reviewed by your IRB and either be approved, or considered exempt from human subjects research guidelines. Once irbDecisionOn is set, irbDecisionType and irbExpiresOn must also be set.
irbDecisionType (Y) The type of decision issued by the IRB, either approved or exempt.
irbExpiresOn (Y) The last date that the IRB’s review is considered up-to-date for this study.

A contact contains the following information:

Field Required Description
name Y The name of the person or organization, e.g. “Dr. Tim Powers, Ph.D.” or “Sage Bionetworks”.
role Y The purpose of the contact. The values that are supported include irb, principal_investigator, investigator, (fiscal) sponsor, study_support and technical_support.
position N The position of an individual relative to their institutional affiliation (not their role in the study, please use the role attribute for this). For example, “AssociateBioengineering.”
affiliation N The organization an individual is affiliated with, e.g. "UC San Francisco”. This may or may not be the same as the institution sponsoring the study.
address N The full mailing Address, if required (see below).
email N Email address of an individual or organization.
phone N Phone number of an individual or organization.
jurisdiction N The regulatory jurisdiction of this entry. When multiple jurisdictions are involved in a study, there may be principal investigators, IRBs, and study coordinators involved from each jurisdiction. It may be useful to show a participant the people and organizations involved in their specific jurisdiction, or the primary jurisdiction and their specific jurisdiction, or all jurisdictions.

The Address is suitable for displaying an address to end users.

Field Required Description
placeName N The name of a building, or sometimes the name of the organization at the address.
street N A street (usually a number and a name, but anything that defines the locality).
mailRouting N Mail routing information such as a unit, P.O. box, mail stop, or other directions on where to deliver mail at the locality.
city N City. In the example from the Philippines above, there are two municipalities specified.
division N state, province, prefecture
postalCode N Zip code, post code, etc.
country N Country.

Here are some examples of more unusual addresses and how they might be stored:

50 miles (80 km) West of Socorro, New Mexico, USA
mailRouting = “50 miles (80 km) West of”
city = “Socorro”
division = “New Mexico”
country = “USA”
647 National Road
16 Sunlight Building
Barangay Muzon, Taytay, Rizal
Taytay CPO-PO Box# 1920 + Rizal
placeName = “647 National Road”
street = “16 Sunlight Building”
city = “Barangay Muzon, Taytay”
division = “Rizal”
mailRouting = “Taytay CPO-PO Box# 1920”
country = “Philippines”


A user must create an account in Bridge before they can be enrolled in a study. There are three ways to be enrolled in a study:


The user creates an account, using the SignUp API, verifies their email or phone number, and then attempts to sign in. Upon detection that the user is not consented to participate in research (the user receives a 412 exception), the user is presented with the ability to consent using Bridge’s electronic consent APIs. When the user signs the consent for a study, they are enrolled in that study. Note that the user no longer receives a 412 after being enrolled in at least one study, so the UserSession may need to be examined to determine if the user is in a particular study.

Manual enrollment by study administrator

An administrator manually enrolls an existing participant, optionally providing an external ID to identify the participant in the study. Only the userId is required in the Enrollment payload for this call.

An administrator creates an account directly enrolled in a study. This last option is necessary to create accounts that have only an external identifier as an authentication credential (you cannot add an external identifier to an account after it is created, if it is the only means of identifying the account other than the user's record ID).

In the latter two cases where an administrator is enrolling a user on their behalf, external partners are responsible for ensuring they meet their IRB’s requirements for informed consent of the participant.

Enrollments can be enumerated for a study (including the number of participants who have withdrawn from the study). Users can withdraw from a study or withdraw from all studies in an app.

In the user’s session, enrollments are given with the following JSON through two read-only properties, studyIds and externalIds:

  "studyIds": ["study1", "study2"],
  "externalIds": {
    "study1": "externalId1",
    "study2": "externalId2"
  "type": "UserSessionInfo"

External IDs

An external ID is an identifier that is created and managed outside of Bridge, but associated to a user’s account so researchers can re-identify users at a later time (if they hold a mapping for these identifiers). The External identifiers APIs allow you to create and enumerate accounts using only an ExternalIdentifier object.

You may wish to create accounts that are only identifiable by an external ID. Sage Bionetworks does not recommend this practice for two reasons:

  1. The only way we can authenticate such an account is by using the external ID as a credential (instead of an email or phone number), but by its nature, it cannot be too difficult for participants to enter, so it is usually not complex enough to evade brute force attacks;
  2. If the account does not have a phone number or email address, we cannot trigger a “reset password” worfklow for the user. You will either need to create the account with a password and communicate that to the user, or we have seen implementers hard-code the password for an app, which is not secure.

Bridge recommends use of the phone number of the user’s device as an account credential, as it provides a balance of security and anonymity for the account holder, with a fallback to email address for those devices that do not have a phone number.

Participant APIs

A more complete view of the participants’ in a study can be retrieved through the Study participant APIs. Many additional APIs exist to work with an enrolled account in a study, such as to resend an email verification request or to withdraw a participant from the study.